Raffles Hospital is a tertiary care private hospital of the Raffles Medical Group, a private healthcare provider in Singapore.

There are 380 beds in Raffles Hospital.

During the past decade, Raffles Hospital conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 11 clinical trials were completed, i.e. on average, 61.1% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 10 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Raffles Hospital" #1 sponsor was "Pfizer" with 5 trials, followed by "Millennium Pharmaceuticals, Inc." with 2 trials sponsored, "Alios Biopharma Inc." with 1 trials sponsored, "Arcus Biosciences, Inc." with 1 trials sponsored and "BeiGene" with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Raffles Hospital" #1 collaborator was "BeiGene" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator, "National Cancer Center Singapore, Singapore" with 1 trials as a collaborator and "National University Hospital, Singapore" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Raffles Hospital" are "Carcinoma, Non-Small-Cell Lung" (3 trials), "Ovarian Cancer" (3 trials), "ACUTE LYMPHOBLASTIC LEUKEMIA" (1 trials), "Advanced or Inoperable Gastric Cancer" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Raffles Hospital" in a lesser frequency.

Most popular intervention types in "Raffles Hospital" are "Drug" (19 trials), "Biological" (2 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "ALS-008176" (1 trials), "Alpelisib" (1 trials), "Anastrozole" (1 trials) and "Avelumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Raffles Hospital" are 18 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Raffles Hospital". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Raffles Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Raffles Hospital, 3 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".

Raffles Hospital has several departments that took part in Clinical trials: "Raffles Radiology" - 2 trials